CPRX FY 2016 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

CPRXCatalyst Pharmaceuticals, Inc.

$3B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$43,406

Operating Income

-$19M

Net Income

-$18M

EPS (Diluted)

$-0.22

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$42M

Total Liabilities

$2M

Stockholders' Equity

$39M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$43,406	-$34,468	-25.9%
Operating Income	-$19M	-$20M	+5.5%
Net Income	-$18M	-$20M	+10.7%